NCT02907827View on ClinicalTrials.gov

Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Melanoma
Interventions
OTHER

follow up DW MRI

Whole-body diffusion-weighted magnetic resonance imaging and cfDNA analysis

Trial Locations (2)

1090

RECRUITING

UZ Brussel, Jette

RECRUITING

UZ Brussel, Brussels

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER